Prostaglandin Dz (PGD z ) is the most common prostaglandin type of tile rat brain. Recently a neurornodulator role for PGD z has been suggested. In the present work the central cardiovascular and thermal effects of PGDz were studied in urethane-anaesthetised rats. Mlen adrndnistered at the doses of 0.001-10 ~g/rat into the lateral cerebral ventricle(i.c.v.), PGD2 slightly increased the blood pressure, heart rate and body ternperaure.
INTRODUCTION
Prostaglandin D£ (PG~) is the IOOst common prostaglandin type in the brain of the rat (2), but its possible physiological functions in the central nervous system are not known. Some investigators have suggested that prostaglandins may be involved in the central control of the cardiovascular and thermoregulatory systems (3,4,5). The highest activity of the PGD synthetase in the rat brain has been fOtmd in the hypothalanrus and thalamus (6) , the brain areas important for cardiovascular (7) and thermal (3, 8) homeostasis. Prostaglandins of the E-type are known to be highly active hyperthermic agents in the brain (8, 9) . In additi?n, central administration of PGE2 or PGF~ induce strong dose-related Increases in blood pressure, heart rate and body temperature of the urethaneanaesthetised rat (1,4). Recently it has been reported that PGDz at a dose of 10 ~g/rat raise the blood pressure and heart rate, when adJ:dnistered intracerebroventricularly (i.c.v.) to the urethane-anaesthetlsed rat (10) . However, only two doses were used and therefore the dose-response relationships are not known.
In the present study increasing doses of PGD 2 were ~drrdniste~ed Lc.v. or intravenously (Lv.) to the urethane-anaesthetIsed rat In order to obtain complete simultaneous cumulative dose-response curves for blood pressure, heart rate and body temperature. Since sodi~ mec1o-fenamate interferes with the effects of exogenous prostaglandlns both in the peripheral tissues (11, 12) and in the brain (4,13), it seemed worthwhile to investigate the influence of this agent on the central effects of PGD z . For comparison, the effect of indomethacin, an equally effective inhibitor of prostaglandin synthesis as sodium meclofenamate (14) , was also studied.
MATERIALS AND METHODS
Male Wistar rats (260-360 g) were used. The rats were accoJ1Ddated to standard ambient conditions for at least one week before the experiments. The lights were on from 6 a.m. to 6 p.m. and the room was completely dark during the remaining 12 hours. The temperature was kept at 22 C and the relative humidity at 40%. lhe rats received standard rat pellets (Hankkija Oy., Helsinki) and tap water ad libitum.
The rats were anaesthetised with urethane (1.5 g/kg intraperitoneally). The trachea was cannulated with a polyethylene tube and the rats were allowed to breathe spontaneously. The mean arterial blood pressure was measured from tile left feJ1Dral artery by means of a pressure transducer (llewlett Packard 1280). The heart rate was calculated from the pulse waves by reans of a rate computer (Hewlett Packard 8812 A). The left femoral vein was cannulated for intravenous injections. The rats were mounted in a stereotaxic instrument and tilted caudally so that the body fonned an angle of 10 degrees with the horizontal plane. Intracerebroventricular injections were perforred as described by Paakkari(ls). Briefly, an injection needle was introduced into the right lateral ventricle of the brain. A polyethylene catheter, filled with the drug or control solution to be infused, was attached to the needle and the desired arount of the solution was allowed to flow slowly by virtue of the hydrostatic pressure. The proper position of the needle tip was ascertained at the end of each experiment by an injection of dye (Giemsa Solution, Merck) into the cerebral ventricle. The body temperature was measured rectally with a temperature recorder (ELLAE instruments, type TE 3, Copenhagen), a probe being introduced 5 cm into the rectum. A 60 W heating lamp was placed 20 cm above the rat. This distance of the heating lamp was adequate to keep the body temperature of the control rats at 36.9 ± 0.3 C (mean ± s.e.m.) in an ambient temperature of 22 C.
Administration of drugs
Prostaglandin D2 (PGD2), kindly supplied by Dr. J. Pike of the Upjohn Companies, was dissolved in absolute ethanol and stored at -20 C. F~rther dilutions were made freshly each day in a modified Krebs-Ringer bIcarbonate buffer (4) for Lc.v. injections and in 0.9 %(w/v) NaCl (saline) for i.v. injections. The i.c.v. injections were performed in a volume of 10 jJl each and the Lv. injections in a volume of 0.15 ml each. ~le control animals re~eived the same volume of the appropriate vehicle In each case. IncreasIng doses of PGD2 were administered Lc.v. at 20 min intervals in order to obtain cumulative dose-response curves. TI1is interval was chosen because in the preliminary experiments (6 rats for each dose) the maximtnn tachycardic and hyperthermic effects of PGD 2 were reached 10-20 min after each Lc.v. injection. The maximum pressor effect, however, became apparent 5 min after each Lc.v. injection. For comparison, the i.v. injections were also repeated at 20 nUn intervals to make sure that the effects induced by centrally administered PGD 2
were not due to a leakage of the drug into the peripheral circulation. The Student's t-test was used to calculate the statistical significance of the differences between the control and experimental groups.
RESULTS

Effects of prostaglandin D Z in non-pretreated rats
Intracerebroventricularly, PGD z at the doses of 0.001-1 ~g/rat induced rises of blood pressure. The maxirm.nn pressor effect was reached 5 rnin after each i.c.v. injection. The highest dose of 10 ~g/rat caQsed an initial hypotensive effect with its maximum at 1-2 min after each injection. Intravenous administration of PGD2 (0.1-10 ]..lg/rat induced initial falls in blood pressure followed by slight increases in blood pressure. The maxinrum hypo tens i ve effect was reached 1-2 min after each i. v. injection. (Fig. 1) PGD z induced a dose-related tachycardic effect, when adrrUnistercd at the doses of 0.001-10 ]..lg/rat Lc.v. The maximum effect \;Jas reached 10-20 min after each Lc.v. injection. Intravenously, the same doses slightly increased the heart rate. (Fig. 2) PGDz i.c.v. (0.001-10 ~g/rat) increased dose-dependently also the body temperature. The maximum hyperthennic effect was reached 20 min after each i.c.v. injection. Intravenously, the same doses caused only negligible increases in body temperature. (Fig. 3) .
Effects of indomethacin and sodium meclofenamate
Centrally adndnistered indomethacin or sodium meclofenamate (1 mg/ rat i.c.v.) had no significant effects of their own on the blood pressure, heart rate or body temperature of urethane-anaesthetised rats. There were thus no statistically significant differences in the baseline levels of blood pressure, heart rate and body temperature between indomethacin, sodium meclofenamate and vehicle pretreated groups before commencement of the administrations of PGD2i.c.v. (see Fig. 4 ). Effects of prostaglandin D Z in indometha~in and sodium meclofenamate pretreated rats (FIg. 4) Central pretreatment with indomethacin (1 mg/rat i.c.v.~ effectively antagonised the hypertensive, tachycardic and hyperthermlc effects of centrally administered PGD z • Pre~reatment of the rats with sodium meclofenamate (1 mg/rat i.c.v.) completely blunted the PGDz-induced central rises of blood pressure, heart rate and body temperature. DISCUSSION PGD z i.c.v. at the doses of 0.001-10 ~g/rat raised the blood.p:essure of uretilane-anaesthetised rats. The highest dose induced an lllltial decrease in blood pressure, followed by the hypertensive response. I.c.v. administered PGD 2 also dose-dependently increased the heart rate and body temperature of the rats. The effects of PGD2 were not due t<;> any leakage of the drug into the peripheral circulation but to an actIon upon the central nervous system, since upon intravenous injections the same doses first decreased and then only slightly increased the blood pressure and had only weak tachycardic and hyperthermic effects. The antagonism of the central cardiovascular and thermal effects of PGD2 by i. c. v. pretrea tments with indomethacin or sodium meclofenamate further supports the assumption of a central site of action for PGD2'
In agreement with the present results i.c.v. administered PGDz at a dose of 10 ~g/rat slightly increased the blood pressure and heart rate of the ureU1ane-anaesthetised rat (10) . Negligible rise of body temperature has also been reported following i.c.v. injections of PGD z in conscious rats (16) and cats (17) . The rise of blood pressure after the administration of the smallest dose of PGD2 preceded the increases in heart rate and body temperature. Hence, the hypertensive response to PGD z is not a consequence of the increased body temperature, and PGDz see~ to be more potent in inducing changes in blood pressure than in heart rate and body temperature.
PGD z is the lIJ)st COJI1lOOn prostaglandin type in the rat brain (2). Therefore the fonnation of PGD 2 in the brain might, under S0100 physiological or pathophysiological conditions, influence cardiovascular and the:rm:>regulatory systems. In fact, the central effects of PGD2 were very similar to those of arachidonic acid (18, 19) , the precursor of prostaglandins (14) . However, PGD z was less potent than PGE z (1) or PGFza (4, 10) ~ inducing increases in blood pressure, heart rate and body temperature In the urethane-anaesthetised rat. Therefore, in spite of the abundance of PGD z in the rat brain, the weak potency does not suggest an important role for this compound in the central control of the cardiovascular and thenooregulatory systems.
Central pretreatment with indomethacin or sodium meclofenamate effec~i~ely antagonised the cardiovascular and thermal responses to i.c.v. adminIstered PGDz• In agreement with the present findings an antagonism of the effects of exogenous prostaglandins by fenarnates and indomethacin has been reported in several tissues: Sodium meclofenamate and other fe~amate7 antagonise th: effects of exogenous prostaglandins in rat, gumea-plg and human allJl'entary muscle (11, 12) , human bronchial nruscle (20) ! an~ these drugs attenuate the PGF 2 a-induced bradycardia and hypoenslon ln the cat· (21) and prostaglandin-induced gastric acid secretion ill the rat (22) . Furthenoore, the central hypotensive effect of PGI 2 was antagonised by sodium meclofenamate (13) . Indomethacin has been repqrted to blunt the PGDz-induced contractions of the longitudinal nruscle of rat gastric fundus (12) and to reduce submaximal contractions to PGE 1 in gerbil colon (23) . Antagonism of the prostaglandin action by indumethacin has also been demonstrated in rat uterus (24) and in isolated guinea-pig ileum and rabbit ear preparations (25) . Indomethacin partly antagonised also the central effects of PGE z on blood pressure, heart rate and body temperature of the urethane-anaesthetised rat, while sodium meclofenamate blunted only the hypertensive effect of centrally administered PGE z (1). Indomethacin and mefenamdc acid both interfere with tile 3H-PGE 1 -binding in rat epididymal fat cells suggesting that tllese agents may directly interact with PGE 1 at a common receptor (23).
However, both indomethacin and fenamates effectively inhibit also the synthesis of prostaglandins (14) . The total amount of prostaglandins, endogenous plus exogenous, present at the receptors may be decreased by inhibitors of prostaglandin synthesis. Therefore the possibility cannot be excluded that the effects of indOIrethacin and sodium lOOclofenamate might be at least parly due to the inhibition of the endogenous prostaglandin synthesis and not solely to the blockade of prostaglandin receptors.
